Over $15.5M Bet On ModivCare? Check Out These 4 Stocks Insiders Are Buying
Portfolio Pulse from Lisa Levin
Insider trades were noted in four US-listed companies: Akero Therapeutics, ModivCare, TreeHouse Foods, and V.F. Corporation. Akero Therapeutics' Director acquired 25,000 shares at an average price of $42.06, following the company's recent successful SYMMETRY study. ModivCare's Director bought 435,893 shares at an average price of $35.74, despite the company's weaker-than-expected quarterly results. TreeHouse Foods' 10% owner purchased 41,500 shares at an average price of $46.11, after the company reported a 4.1% YoY sales growth. V.F. Corporation's Director bought 40,000 shares at an average price of $19.09, despite the company's wider-than-expected Q1 loss.
August 11, 2023 | 1:03 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
ModivCare's Director bought 435,893 shares despite the company's weaker-than-expected quarterly results.
The insider purchase may signal a belief in the company's long-term prospects, but the recent weak quarterly results could limit short-term gains.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 100
NEUTRAL IMPACT
V.F. Corporation's Director bought 40,000 shares despite the company's wider-than-expected Q1 loss.
The insider purchase may indicate confidence in the company's long-term prospects, but the recent Q1 loss could limit short-term gains.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 100
POSITIVE IMPACT
Akero Therapeutics' Director bought 25,000 shares following the company's successful SYMMETRY study.
The insider purchase indicates confidence in the company's prospects, potentially leading to a positive short-term impact on the stock.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
TreeHouse Foods' 10% owner bought 41,500 shares after the company reported a 4.1% YoY sales growth.
The insider purchase, combined with the company's strong sales growth, could lead to a positive short-term impact on the stock.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100